Precision Biosciences (DTIL) Other Non Operating Income (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Other Non Operating Income data on file, last reported at -$9.4 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 705.43% year-over-year to -$9.4 million in Q1 2026; TTM through Mar 2026 was -$5.3 million, a 124.18% decrease from a year earlier, with the FY2025 full-year figure at $5.5 million, down 83.38% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$9.4 million, down from $6.8 million in the prior quarter.
• Over the last five years, Other Non Operating Income for DTIL reached as high as $12.8 million in Q1 2024 and fell as low as -$9.4 million in Q1 2026.
• Historically, Other Non Operating Income has averaged $1.2 million across 5 years, with a median of $96000.0 in 2023.
• Across the five-year window, Other Non Operating Income sank 6270.83% in 2022 and jumped 8861.46% in 2024, its largest moves.
• Year by year, Other Non Operating Income stood at -$7.3 million in 2022, then soared by 119.9% to $1.5 million in 2023, then soared by 387.71% to $7.1 million in 2024, then declined by 4.68% to $6.8 million in 2025, then plunged by 238.37% to -$9.4 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$9.4 million in Q1 2026, $6.8 million in Q4 2025, and -$1.1 million in Q3 2025.